BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 1739240)

  • 1. Wegener granulomatosis: an analysis of 158 patients.
    Hoffman GS; Kerr GS; Leavitt RY; Hallahan CW; Lebovics RS; Travis WD; Rottem M; Fauci AS
    Ann Intern Med; 1992 Mar; 116(6):488-98. PubMed ID: 1739240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wegener granulomatosis in children and adolescents: clinical presentation and outcome.
    Rottem M; Fauci AS; Hallahan CW; Kerr GS; Lebovics R; Leavitt RY; Hoffman GS
    J Pediatr; 1993 Jan; 122(1):26-31. PubMed ID: 8419611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.
    Villa-Forte A; Clark TM; Gomes M; Carey J; Mascha E; Karafa MT; Roberson G; Langford CA; Hoffman GS
    Medicine (Baltimore); 2007 Sep; 86(5):269-277. PubMed ID: 17873756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
    Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
    Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.
    Langford CA; Talar-Williams C; Barron KS; Sneller MC
    Am J Med; 2003 Apr; 114(6):463-9. PubMed ID: 12727579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.
    Talar-Williams C; Hijazi YM; Walther MM; Linehan WM; Hallahan CW; Lubensky I; Kerr GS; Hoffman GS; Fauci AS; Sneller MC
    Ann Intern Med; 1996 Mar; 124(5):477-84. PubMed ID: 8602705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
    Sneller MC; Hoffman GS; Talar-Williams C; Kerr GS; Hallahan CW; Fauci AS
    Arthritis Rheum; 1995 May; 38(5):608-13. PubMed ID: 7748215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.
    Fauci AS; Haynes BF; Katz P; Wolff SM
    Ann Intern Med; 1983 Jan; 98(1):76-85. PubMed ID: 6336643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.
    Langford CA
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):31-4. PubMed ID: 21447129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate treatment of Wegener granulomatosis in children.
    Gottlieb BS; Miller LC; Ilowite NT
    J Pediatr; 1996 Oct; 129(4):604-7. PubMed ID: 8859270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.
    Hoffman GS; Leavitt RY; Fleisher TA; Minor JR; Fauci AS
    Am J Med; 1990 Oct; 89(4):403-10. PubMed ID: 2220874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and therapeutic aspects of the surgical approach to Wegener's granulomatosis.
    Flye MW; Mundinger GH; Fauci AS
    J Thorac Cardiovasc Surg; 1979 Mar; 77(3):331-7. PubMed ID: 762975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH;
    Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wegener granulomatosis in pediatric patients.
    Hall SL; Miller LC; Duggan E; Mauer SM; Beatty EC; Hellerstein S
    J Pediatr; 1985 May; 106(5):739-44. PubMed ID: 3998914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wegener granulomatosis in childhood: prolonged survival following cytotoxic therapy.
    Moorthy AV; Chesney RW; Segar WE; Groshong T
    J Pediatr; 1977 Oct; 91(4):616-8. PubMed ID: 908985
    [No Abstract]   [Full Text] [Related]  

  • 17. Wegener granulomatosis and trimethoprim-sulfamethoxazole. Complete remission after a twenty-year course.
    West BC; Todd JR; King JW
    Ann Intern Med; 1987 Jun; 106(6):840-2. PubMed ID: 3495214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic manifestations of Wegener granulomatosis: diagnosis and course.
    Aberle DR; Gamsu G; Lynch D
    Radiology; 1990 Mar; 174(3 Pt 1):703-9. PubMed ID: 2305053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Wegener's granulomatosis (morbus Wegener)].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2003 Nov; 92(46):1943-7. PubMed ID: 14765551
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept plus standard therapy for Wegener's granulomatosis.
    Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
    N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.